Cartesian Therapeutics, Inc.RNACNASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
93.99%
↑ 321% above average
Average (9y)
-42.58%
Historical baseline
Range
High:208.75%
Low:-778.85%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 93.99% |
| 2023 | -778.85% |
| 2022 | 208.75% |
| 2021 | 66.99% |
| 2020 | 43.99% |
| 2019 | 58.36% |
| 2018 | 8.75% |
| 2017 | 7.32% |
| 2016 | -36.59% |
| 2015 | -98.56% |